Sandbox Reserved 712: Difference between revisions
| Line 21: | Line 21: | ||
== '''References''' == | == '''References''' == | ||
<references/> | <references/> | ||
(1) Kohl, N. E., E. A. Emini, W. A. Schleif, L. J. Davis, J. C. Heimbach, R. A. F. Dixon, E. M. Scolnick, and I. S. Sigal. 1988. Active human immunodeficiency virus protease is required for viral infectivity. Proc. Natl. Acad. Sci. USA 85:4686-4690. | |||
== '''Contributors''' == | == '''Contributors''' == | ||
Julia Baaske, Angelika Wackerl | Julia Baaske, Angelika Wackerl | ||
Revision as of 12:00, 27 December 2012
|
Description
3ggu is a drug resistant HIV protease. Shown is a patient's variant in complex with darunavir.
HIV proteases are essential for the functioning of the retrovirus that causes AIDS. HIV needs active proteases to process Gag & Gap - Polymerase polyprotein precursors into mature structural proteins and replicative enzymes. HIV proteases contain a highly conserved region Asp - Thr - Gly (Asp25, Thr26 and Gly27), with the aspartic residue beeing the active site in the aspartyl protease.(1)
Activity
Structure
Applications
External Resources
References
(1) Kohl, N. E., E. A. Emini, W. A. Schleif, L. J. Davis, J. C. Heimbach, R. A. F. Dixon, E. M. Scolnick, and I. S. Sigal. 1988. Active human immunodeficiency virus protease is required for viral infectivity. Proc. Natl. Acad. Sci. USA 85:4686-4690.
Contributors
Julia Baaske, Angelika Wackerl
